US drugmaker Bristol Myers Squibb buys Mirati for $4.8bn

US pharmaceutical company Bristol Myers Squibb announced a $4.8 billion deal on Sunday to acquire cancer drugmaker Mirati Therapeutics.

from Medical Xpress - latest medical and health news stories https://ift.tt/8w9k1uY